Elizabeth Balta
CIK: 0001884087
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
JBIO
Jade Biosciences, Inc.
Officer
Discretionary Trading P&L
Holdings
About Balta Elizabeth
Balta Elizabeth (SEC CIK 0001884087) files insider reports with the SEC as Officer of Jade Biosciences, Inc. (JBIO).
Signal8 holds 2 ownership filings by Balta Elizabeth (1 Form 3, 1 Form 4), filed between May 1, 2025 and Feb 13, 2026. Those filings report 1 transaction, the latest on Feb 12, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Balta Elizabeth's filings is in WALTHAM, MA.
Recent filings by Balta Elizabeth
- Feb 12, 2026: Grant or award of JBIO shares (Form 4, code A).
Other insiders filing for Jade Biosciences, Inc. (JBIO)
- Eisner Mark, Director
- CAIN CHRISTOPHER W., Director
- DOBMEIER ERIC, Director
- Klein Lawrence Otto, Director
- Lavelle Erin, Director
- Fairmount Funds Management LLC, Director